Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Interactive Informed Consent and Education Program for Pregnant Women

This study has been completed.
Sponsor:
Collaborator:
ArchieMD
Information provided by (Responsible Party):
William Grobman, Northwestern University
ClinicalTrials.gov Identifier:
NCT01176019
First received: August 3, 2010
Last updated: November 5, 2014
Last verified: November 2014
  Purpose

The purpose of this study is to determine whether an interactive education program for prenatal testing is effective in improving pregnant women's understanding of and expectations towards prenatal screening and diagnosis.


Condition Intervention Phase
Pregnancy
Down Syndrome
Device: Information about Prenatal Screening and Diagnosis
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Health Services Research
Official Title: An Interactive Informed Consent and Education Program for Pregnant Women

Resource links provided by NLM:


Further study details as provided by Northwestern University:

Primary Outcome Measures:
  • Difference in understanding/knowledge gain as compared to control [ Time Frame: Post-test and 2 week follow-up ] [ Designated as safety issue: No ]
    Open-ended and T/F questionnaire designed to determine if the ArchieMD Interactive Informed Consent and Education Program for Pregnant Women improves understanding and expectations of prenatal screening and diagnostic tests in a group of pregnant women patients.


Secondary Outcome Measures:
  • eHEALS [ Time Frame: Post-test ] [ Designated as safety issue: No ]
    The eHEALS is a self-report tool that can be administered by a health professional and is based on an individual's perception of her or his own skills and knowledge within each measured domain. The instrument is designed to provide a general estimate of consumer eHealth-related skills that can be used to inform clinical decision making and health promotion planning with individuals or specific populations.

  • Attitudes towards/satisfaction with interactive video [ Time Frame: Post-test ] [ Designated as safety issue: No ]
    Multiple-choice questionnaire designed to determine if the ArchieMD Interactive Informed Consent and Education Program for Pregnant Women enhances satisfaction with and attitudes toward the patient education process.

  • REALM [ Time Frame: Post-test ] [ Designated as safety issue: No ]
    The REALM (Rapid Estimate of Adult Health Literacy in Medicine) is a word recognition test designed to provide a valid and quick assessment of participant health literacy.


Enrollment: 150
Study Start Date: August 2010
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Interactive Video
In addition to standard care, the experimental arm will receive an interactive video designed to inform and educate patients about the choices that exist concerning prenatal screening and diagnosis.
Device: Information about Prenatal Screening and Diagnosis
15-20 minute interactive video about prenatal screening and diagnosis given on day of recruitment.
No Intervention: Control
A control arm will receive standard care, which is the opportunity to meet with a genetic counselor.

Detailed Description:

Women face a variety of medical decisions during pregnancy and childbirth. While there are extensive educational resources for pregnant women, modern medicine presents decisions that many women are poorly equipped to make. Issues such as prenatal screening and mode of birth after a cesarean delivery require a significant degree of patient education to enable a truly informed medical decision. Studies have shown that women have a poor understanding of screening for birth defects and mode of birth after a cesarean delivery. Women with a low level of education or poor health literacy are significantly more likely to demonstrate inadequate understanding of prenatal screening. ArchieMD, Inc. has developed a comprehensive interactive medical simulation environment which has the potential to visually convey complex information to patients to improve understanding of medical procedures and educate patients on the consequences of their behavior. We hypothesize that such an interactive medical simulation patient education program can improve patient understanding allowing pregnant women to make informed decisions. In Phase I, we will prototype an interactive patient education program for prenatal screening and amniocentesis.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant woman (6-26 weeks gestation)
  • Over 18 years of age

Exclusion Criteria:

  • Non-English speaking
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01176019

Locations
United States, Illinois
Northwestern Memorial Faculty Foundation (NMFF)
Chicago, Illinois, United States, 60611
Northwestern Memorial Hospital (NMH)
Chicago, Illinois, United States, 60611
Sponsors and Collaborators
Northwestern University
ArchieMD
Investigators
Principal Investigator: Bill Grobman, M.D., M.B.A Northwestern University
Principal Investigator: Michael Wolf, Ph.D, M.P.H Northwestern University
Principal Investigator: Robert Levine, M.D. ArchieMD, Inc.
  More Information

No publications provided

Responsible Party: William Grobman, Associate Professor, Northwestern University
ClinicalTrials.gov Identifier: NCT01176019     History of Changes
Other Study ID Numbers: NIH-291
Study First Received: August 3, 2010
Last Updated: November 5, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Northwestern University:
Amniocentesis
Chorionic Villus Sampling
First trimester screening
Down syndrome

Additional relevant MeSH terms:
Down Syndrome
Syndrome
Abnormalities, Multiple
Chromosome Disorders
Congenital Abnormalities
Disease
Genetic Diseases, Inborn
Intellectual Disability
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes

ClinicalTrials.gov processed this record on November 25, 2014